As the healthcare industry has experienced growing pressure to adopt a focus on care quality and health outcomes while reducing costs, traditional delivery and payment models continue giving way to new approaches. A growing universe of provider networks, such as accountable care organizations (ACOs) and integrated delivery networks (IDNs), are beginning to reshape the way care is provided and clinical decisions are made. As a result, life sciences companies can no longer view the U.S. as a national market-or pursue it with a single brand strategy and individual, physician-focused sales and marketing tactics. In this white paper, IMS Health explains the stakeholders in each market, why IDNs matter in a market, and how advanced analytics can be used to assess an IDN's market reach, physician influence and brand impact.

New Pharmaceutical Marketing Practices Making customer data actionable

Today's always-on customers seek more than mere transactions with brand marketers; they seek seamless, on-demand experiences. And delivering those experiences requires new data management and marketing tools./

It's a whole new world for healthcare. Old business models and traditional incumbents are being challenged by new players, and the balance of power among payers, providers, HCPs, and consumers is rapidly shifting.

Download our whitepaper and learn how today's healthcare marketers can leverage digital channels using first and third-party consumer data to deliver more relevant messaging to patients, caregivers, physicians and other influencers.